In trading on Friday, shares of Medicines Co (MDCO) touched a new 52-week high of $45.31/share. That's a 64.76% rise, or $17.81 per share from the 52-week low of $27.50 set back on 02/11/2016. That means at today's intraday high, any investor who purchased MDCO stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, MDCO has seen 2 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
12/08/2016 Fredric N. Eshelman Director 621,720 $33.77 $20,993,462.41
12/08/2016 Christopher T. Cox EVP & Chief Corp. Dev. Officer 105,500 $33.20 $3,502,950.00

The chart below shows where MDCO has traded over the past year, with the 50-day and 200-day moving averages included.

Medicines Co  Moving Averages Chart

In afternoon trading on Friday, MDCO shares are changing hands at $44.90/share, slightly below the new 52-week high.

More from Stocks

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump